Skip to main content
. Author manuscript; available in PMC: 2013 Apr 23.
Published in final edited form as: Cell Rep. 2013 Feb 14;3(2):371–385. doi: 10.1016/j.celrep.2013.01.023

Figure 4. MAb 72A1, Directed to N-terminal Gp350/220 Blocks Infection of CD35 Expressing Nalm6 and K562+ lines.

Figure 4

Top, Nalm6 CD21, CD35 and Raji (control) are susceptible to EBV infection, whereas Nalm6 is not, as shown by EGFP visualization at 72 hr. Pre-incubation of EBV with anti-gp350/220 (mAb 72A1) blocks infection of CD21 and/or CD35+ cells. Bottom, Infection of all K562+ receptor-bearing lines is likewise blocked when EBV is pre-incubated with mAb 72A1.